Medicine-taking experiences and associated factors: comparison between Arabic-speaking and Caucasian English-speaking patients with Type 2 diabetes

Diabetic Medicine : a Journal of the British Diabetic Association
H AlzubaidiJ Marriott

Abstract

The aim of this study was to explore and compare medication-taking experiences and associated issues in Arabic-speaking and Caucasian English-speaking patients with Type 2 diabetes in Australia. Various healthcare settings in metropolitan Melbourne, Australia, were purposefully selected to obtain a diverse group of participants with Type 2 diabetes. Recruitment occurred at diabetes outpatient clinics in two tertiary referral hospitals, six primary care practices and ten community centres. Face-to-face semi-structured individual interviews and group interviews were employed. All interviews were audiotaped, transcribed and coded thematically. Data collection continued until saturation was reached. In total, 100 participants were recruited into two groups: 60 were Arabic-speaking and 40 were Caucasian English-speaking. Both groups had similar demographic and clinical characteristics. Only 5% of the Arabic-speaking participants had well-controlled diabetes compared with 17.5% of the participants in the English-speaking group. Arabic-speaking participants actively changed medication regimens on their own without informing their healthcare professionals. Arabic-speaking patients had more knowledge gaps about their prescribed treatmen...Continue Reading

References

Apr 29, 1998·BMJ : British Medical Journal·T GreenhalghA M Chowdhury
Jun 24, 2003·Journal of the American Society of Nephrology : JASN·Michael M EngelgauFrank Vinicor
Dec 25, 2003·Diabetes Care·Linda A JaberWilliam H Herman
Apr 28, 2004·Diabetes Care·Joyce A Cramer
Jun 24, 2004·Social Science & Medicine·Robert HorneMatthew Hankins
Jul 9, 2004·The Annals of Pharmacotherapy·Kimberley KrapekTeresa J Lubowski
Nov 25, 2004·Diabetes Care·Manel PladevallJennifer Elston Lafata
Mar 31, 2005·The Diabetes Educator·Mary K RheeLawrence S Phillips
May 17, 2006·International Journal of Clinical Practice·S A Otoom, R P Sequeira
Sep 27, 2006·Archives of Internal Medicine·P Michael HoDavid J Magid
May 23, 2007·Medical Care·M Robin DiMatteoSummer L Williams
Jul 27, 2007·Pharmacy World & Science : PWS·Sarah J Shoemaker, Djenane Ramalho de Oliveira
Dec 7, 2007·The Diabetes Educator·Peggy Soule Odegard, Kam Capoccia
Jul 23, 2008·The Cochrane Database of Systematic Reviews·Kamila HawthorneAdrian Gk Edwards
May 12, 2009·Journal of the American Board of Family Medicine : JABFM·Jeanette M DalyRobert E Garrett
May 28, 2009·Current Medical Research and Opinion·Allison Hedley DoddRonette R Briefel
Aug 7, 2009·Chronic Illness·Jörg W Haslbeck, Doris Schaeffer
Jun 16, 2010·Diabetic Medicine : a Journal of the British Diabetic Association·K HawthorneA G K Edwards
Feb 15, 2011·International Journal of Clinical Practice·C J Bailey, M Kodack
Jan 4, 2012·Diabetes Care·UNKNOWN American Diabetes Association
Feb 19, 2013·Diabetes Care·Sarah Stark CasagrandeCatherine C Cowie

❮ Previous
Next ❯

Citations

Mar 31, 2018·Nursing Open·Samereh AbdoliMartha Funnell
Jun 22, 2018·International Journal of Clinical Pharmacy·Hamzah AlzubaidiKevin Mc Namara
Sep 12, 2018·Journal of Immigrant and Minority Health·Ariel Yeheskel, Shail Rawal
Nov 9, 2019·International Journal of Clinical Pharmacy·Anna Wahyuni WidayantiJames A Green
Jan 6, 2021·Pharmacy : Journal of Pharmacy, Education and Practice·Lisa A HillmanJon C Schommer
Sep 30, 2021·International Journal of Clinical Pharmacy·Hamzah AlzubaidiColette Browning

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.